Evidence map›Paper›PMID 39246497›Full record

ArticleACS omega2024

Selective Naked-Eye Detection of Lung Squamous Cell Carcinoma Mediated by lncRNA SOX2OT Targeted Nanoplasmonic Probe.

Nastaran Roknabadi, Yasaman-Sadat Borghei, Seyedeh Saina Seifezadeh, Bahram M Soltani, Seyed Javad Mowla

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nastaran RoknabadiDepartment of Molecular Genetics Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, Iran.
Yasaman-Sadat BorgheiCenter for Bioscience & Technology, Institute for Convergence Science & Technology Sharif University of Technology, Tehran 1458889694, Iran.ORCID https://orcid.org/0009-0003-9530-4815
Seyedeh Saina SeifezadehDepartment of Molecular Genetics Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, Iran.
Bahram M SoltaniDepartment of Molecular Genetics Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, Iran.
Seyed Javad MowlaDepartment of Molecular Genetics Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of nanobiotechnology in biomolecule detection can provide fast and accurate tests for diagnosing molecular changing-associated diseases. The use of AuNPs-thiolated probe conjugates has long been considered as an alternative method for the detection of specific DNA/RNA targets. Here, we present a colorimetric direct detection method for the SOX2OT transcript, long noncoding RNAs (lncRNAs), by using a poly guanine tail (G12) as a template for in situ synthesis of gold nanoparticles (AuNPs) without any chemical modification or DNA labeling. We have then developed this proposed detection system based on two complementary sequences of long noncoding RNA SOX2OT with an extra strand of poly G12. Using this method, we were able to differentiate lung squamous cell carcinoma from adenocarcinoma samples. Based on this disclosure, this invention provides a simple visual method to detect specific lncRNA sequences without the need for amplifying the target lncRNA and discriminate squamous cell carcinoma from adenocarcinoma samples. Our invention provides a diagnostic kit to detect RNA by means of direct detection (PCR-free) of the lncRNA by in situ synthesis of AuNPs based on two probes with an extra strand of poly G12.

Identifiers

PMID39246497
PMCPMC11375807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.